Please use this identifier to cite or link to this item:
https://dspace.bsmu.edu.ua/handle/123456789/25847| Title: | Inhibition of steatosis and liver fibrosis progression in patients with nonalcoholic steatohepatitis and stage two essential hypertension due to the treatment with hepadif, ezetimibe and fosinopril |
| Authors: | Mandryk, O. Yeleniuk, I. Stasiuk, V. |
| Keywords: | nonalcoholic steatohepatitis SteatoTest FibroTest arterial hypertension |
| Issue Date: | 2021 |
| Citation: | Results of modern scientific research and development: Proc. of the 3rd Int. sci. and pract. conf. (May 29-31, 2021, Madrid, Spain). Madrid: Barca Academy Publishing, 2021. 675 p. |
| URI: | https://dspace.bsmu.edu.ua/handle/123456789/25847 |
| Appears in Collections: | Тези. Кафедра внутрішньої медицини, клінічної фармакології та професійних хвороб |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Mandryk et al. Inhibition.pdf | 337.35 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.